Fierce Biotech, July 10, 2015. Lawmakers in the House easily passed the 21st Century Cures Act today, a big step toward once again shaking up the legal framework built to guide drug development in the U.S. while significantly boosting the amount of funding that flows to the NIH. Consumer advocates, though, see the new development regulations as a recipe for unleashing drugs and devices that would later prove dangerous and unhelpful.
Read More »News That Quotes Us & Our Work
We are often quoted in major newspapers and magazines, and on well-respected TV shows, radio programs, and websites where we share our opinion on issues that matter to you and your health. Stay up to date on health news and our take on it by reading the articles in this section.
House Passes ‘Cures’ Bill to Hasten Drugs to Market
Medscape, July 10, 2015. The House of Representatives overwhelmingly passed a bipartisan bill designed to speed up the development and approval of new drugs and medical devices. “The bill greatly benefits the pharmaceutical industry [and] medical device manufacturers,” said Diana Zuckerman.
Read More »This Bill Promises to Speed Up Drug Approval So Much That It’s Making People Uncomfortable
The Washington Post, July 8, 2015. The bill slated to land on the House floor on Thursday seems unassailable on its face – the 21st Century Cures legislation promises to modernize medicine and speed the development of lifesaving treatments. But a vocal chorus of physicians and pharmaceutical industry watchdogs warn that the bill is full of stealth provisions that could actually put sick people in harm’s way, by speeding the development of treatments that are neither safe nor effective.
Read More »Breasts, Buttocks and Botox – the Surprising Trends in Plastic Surgery
Euro News, June 4, 2015. The American Society of Plastic Surgeons (ASPS) released the detailed figures on cosmetic surgery in 2014, and Euronews outlined seven surprising trends from the US.
Read More »Speeding Up the Drug-approval Process Could Have a Downside
The Wall Street Journal, May 30, 2015. Would a congressional bill designed to jump-start medical innovation end up lowering standards for approving new uses of existing medicines? Consumer advocates are raising this concern about the 21st Century Cures legislation, which passed the House Energy and Commerce Committee unanimously last week and, in part, is designed to reform the approval process for drugs.
Read More »